X

Sarthak Metals Ltd Q3 FY24 Earnings Conference Call Insights

Key highlights from Sarthak Metals Ltd (SMLT) Q3 FY24 Earnings Concall

  • New Business Initiatives
    • Company launching new flux cored wires business with successful trial production runs and BIS certification.
    • Targeting government approvals for railway sector.
    • Launching new biotech division focused on enzymes for ethanol production and other applications.
    • Tied up with CSIR for technology transfer and working with institutes for standardization.
    • Plans to invest INR 100 crores into biotech division to generate INR 350 crores revenue at 30% margin.
  • Financial Performance
    • Revenue down 19% YoY and 3% QoQ to INR 75 crores for 3Q.
    • EBITDA margins affected by lower sales of high margin cored wires and aluminum pricing cycle.
    • Finance cost increased sequentially and YoY to INR 33 lakhs.
    • PAT at INR 1.72 crores.
  • Cored Wire/Aluminium Flipping Coils Business Update
    • Revenue of INR 28 crores in Q3.
    • Lower price realizations and volumes due to multiple factors.
    • Top clients include leading steel manufacturers.
    • Aluminum flipping coils revenue of INR 36 crores in Q3.
    • Painful commodity pricing cycle affecting margins.
  • Growth Opportunities
    • Government’s 20% ethanol blending target by 2025 to require 1,000 crore liters including 100 crore liters 2G ethanol.
    • Biotech enzymes global market over INR 75,000 crores with 10-15% CAGR.
    • Plans to focus on enzymes for ethanol, breweries, textiles, food processing etc.
    • Also focusing on protein nutrition and dietary supplements.
  • Flux Cored Wires Update
    • Early adopter of the technology.
    • Strategic location near major fabrication houses with large order books.
    • Too soon to reveal order book details.
    • Rapidly getting approvals from customers.
    • New segment, confident can utilize 100% capacity in coming quarters.
    • At peak can generate INR 4 crores revenue; plans to scale up capacity.
  • Diversification/Exploration
    • No plans to diversify into other metal sectors currently.
    • Focused on the two new initiatives in flux cored wires and biotech.
    • Biotechnology top focus area currently.
    • Aiming to establish credibility in renewable energy enzymes for ethanol blending.
    • Also want to build a healthcare segment within biotech division.
    • Government support a positive in biotechnology space.
  • Performance vs. Guidance
    • Revenue of INR 236 cr in 9M significantly below full year guidance of INR 400 cr.
    • OPM also lower than guided.
    • Factors contributing to downturn:
      • Lower product realizations hurting revenue and margins.
      • Volatile and cyclical pricing especially for aluminum.
      • Rising input costs but falling output prices.
  • Demand Environment
    • Domestic cored wire sales muted, no change.
    • Increased aluminum sales 20% QoQ.
    • Overall demand still flat, not highly growing.
    • Steel market still in cyclical downturn.
    • Not seeing volume growth to gain market share as indicated.
  • Margins Sustainability/Drivers
    • Current low gross margins not sustainable due to high impact of aluminum business cycle.
    • Also lower cored wire exports due to inventory issues.
    • Aluminum business needs revival to escape pricing cycle.
    • Taking measures like lower inventory to improve situation.
    • Improving product mix toward cored wires.
    • Higher exports and steel quality mix.
    • Improved capacity utilization.
  • Competitive Positioning
    • Facing pricing pressure unable to pass higher costs.
    • Need to clarify competitive edge in this environment.
    • Steel prices rising but unable to take price increases.
  • Outlook
    • Q4 sales expected to remain flat.
    • Margins need price realization to improve.
    • Aluminum highly commoditized, needs price recovery.
    • Global tensions preventing aluminum price increases.
    • FY24 revenue estimate around INR 330 crores.
    • FY25 baseline growth of 10%.
  • Capacity Utilization
    • Cored wires at 60% utilization.
    • Aluminum at 50-60% utilization.
    • Peak revenue at current prices around INR 700-800 crores.
  • Biotech Enzymes
    • New non-core business, a leap for company.
    • Gaining credibility via government collaborations.
    • Detergent companies early focus area.
    • Flagship product for 2G ethanol blending program; order potential on ramp up.
    • Leveraging business experience to enter new area.
    • INR 10 crores investment in FY25; Revenue to start in H2 FY25.
    • INR 100 crores total investment over time.
Related Post